<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Chagas heart disease: Acute myocarditis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Chagas heart disease: Acute myocarditis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Chagas heart disease: Acute myocarditis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Antonio Marin-Neto, MD, PhD, FACC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Benedito C Maciel, MD, FACC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Caryn Bern, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sharon A Hunt, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 09, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3822603367"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Chagas disease (CD) is caused by <em>Trypanosoma cruzi</em>, a protozoan parasite that can cause acute myopericarditis as well as chronic fibrosing cardiomyopathy. CD is the most common cause of non-ischemic cardiomyopathy in Latin America [<a href="#rid1">1</a>].</p><p>Issues related to acute Chagas heart disease will be reviewed here. Issues related to chronic CD including the indeterminate form and chronic Chagas cardiomyopathy are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/114192.html" rel="external">"Chagas disease: Chronic Trypanosoma cruzi infection"</a> and  <a class="medical medical_review" href="/z/d/html/4955.html" rel="external">"Chronic Chagas cardiomyopathy: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/4925.html" rel="external">"Chronic Chagas cardiomyopathy: Management and prognosis"</a>.)</p><p>Issues related to other aspects of Chagas disease are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection"</a> and  <a class="medical medical_review" href="/z/d/html/14004.html" rel="external">"Chagas disease: Antitrypanosomal drug therapy"</a> and  <a class="medical medical_review" href="/z/d/html/5700.html" rel="external">"Chagas gastrointestinal disease"</a>.)</p><p class="headingAnchor" id="H1734503802"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H2908088366"><span class="h2">Signs and symptoms</span><span class="headingEndMark"> — </span>Most patients with acute CD are asymptomatic or have a relatively mild nonspecific illness, with generalized symptoms and signs such as fever and myalgia. A minority of patients have inflammation and swelling at the site of inoculation, known as a "chagoma." When inoculation occurs via the conjunctiva, the patient may present with the Romaña sign, painless unilateral bipalpebral swelling that lasts up to several weeks.</p><p>The acute phase of CD begins after an incubation period of one week to two weeks (following vector-borne transmission) or up to four months following transmission via transfusion or organ transplant [<a href="#rid2">2</a>]. The acute phase of CD typically lasts 8 to 12 weeks (<a class="graphic graphic_figure graphicRef114565" href="/z/d/graphic/114565.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection"</a>.)</p><p>Symptomatic myocarditis is rare when the transmission is through the vector-borne route (a triatomine bug bite with inoculation of infected vector dejecta into the bite wound or mucous membranes). A diagnosis is rarely (estimated as less than 1 to 5 percent) established during the acute phase acquired via vector transmission, given the high rate of no or mild nonspecific symptoms. In contrast, when patients are infected through the oral route (through the ingestion of food contaminated by large loads of <em>T. cruzi</em>) myocarditis is often severe and carries a higher risk of mortality. In addition, a cluster of acute infections due to a common contaminated source, such as juice, is more likely to lead to etiological testing and recognition of the diagnosis than an isolated vector-borne infection that manifests as an undifferentiated febrile illness [<a href="#rid3">3</a>].</p><p>A minority of patients with acute CD present with fulminant disease with acute myocarditis leading to heart failure (HF), pericardial effusion, meningoencephalitis and associated risk of death. HF is associated with significant risk of early mortality. (See  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection"</a>.)</p><p>The clinical manifestations of cardiac involvement in acute CD are similar to those of myocarditis or myopericarditis due to other causes; these include dyspnea, fatigue (and other symptoms and signs of HF), chest pain, arrhythmias, and sudden cardiac arrest [<a href="#rid2">2,4,5</a>]. One nonspecific sign of cardiac dysfunction is tachycardia out of proportion to fever [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/4939.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4930.html" rel="external">"Myopericarditis", section on 'Clinical presentation'</a>.)</p><p>Factors associated with increased risk of severe acute morbidity (particularly myocarditis) and mortality include infection through the oral route and immunosuppression. The frequency and severity of clinical manifestations in the acute phase, including mortality due to myocarditis and/or meningitis-encephalitis, tend to be more prominent in young children [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection"</a> and  <a class="medical medical_review" href="/z/d/html/114195.html" rel="external">"Chagas disease in the immunosuppressed host"</a>.)</p><p class="headingAnchor" id="H1152103613"><span class="h2">Initial test results</span><span class="headingEndMark"> — </span>During the first weeks of infection, serologic tests for <em>T. cruzi</em> infection are usually negative. Other laboratory findings are nonspecific, such as leukocytosis with an absolute increase in lymphocyte count. Since the level of parasitemia is high in the acute phase, the diagnosis is based upon detection of circulating parasites by a variety of methods. (See  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection"</a>.)</p><p>Although symptoms and signs of cardiac disease are commonly lacking, myocardial involvement is likely present in most if not nearly all patients diagnosed with acute CD [<a href="#rid7">7</a>]. Initial cardiac test findings are nonspecific but denote the presence of myocarditis [<a href="#rid4">4,5,8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiographic (ECG) findings may include sinus tachycardia, low voltage, atrial and ventricular premature beats, bundle branch block, diffuse ST-T wave changes, prolonged PR interval, or more advanced atrioventricular block (<a class="graphic graphic_waveform graphicRef121871" href="/z/d/graphic/121871.html" rel="external">waveform 1</a>). Arrhythmias such as atrial fibrillation and ventricular tachycardia are uncommon. During recovery, the ECG findings resolve in over 90 percent of patients within one year.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The chest radiograph frequently demonstrates an enlarged cardiac silhouette (cardiac-to-thoracic width ratio above 50 percent), which may be caused by a pericardial effusion or biventricular chamber dilation (<a class="graphic graphic_diagnosticimage graphicRef121856" href="/z/d/graphic/121856.html" rel="external">image 1</a>).</p><p></p><p>Echocardiography is a key test to assess cardiac involvement as discussed below. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H1752540334"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>A diagnosis of acute Chagas myocarditis is based upon identifying recently acquired CD with associated cardiac involvement:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute CD should be suspected in patients who have an epidemiologic exposure (eg, primary residence in an area of the Americas where vector-borne transmission occurs) and nonspecific symptoms such as malaise, fever, and anorexia. Rarely, patients with acute CD may present with a skin "chagoma" or eyelid swelling (Romaña sign). However, many patients are asymptomatic and do not come to clinical attention. (See <a class="local">'Signs and symptoms'</a> above and  <a class="medical medical_review" href="/z/d/html/5698.html" rel="external">"Chagas disease: Epidemiology, screening, and prevention"</a>.)</p><p></p><p class="bulletIndent1">A diagnosis of acute CD is established by detection of circulating parasites by a variety of methods, as discussed separately. Biopsy of a typical "chagoma" is sometimes useful to establish the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with confirmed acute CD should undergo an initial cardiac evaluation including history, physical examination, ECG, and chest radiograph.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with cardiac symptoms or signs and/or abnormalities on an ECG or chest radiograph, an echocardiogram should be obtained. Diagnosis of cardiac involvement in patients with acute CD is generally confirmed by echocardiography, which is used to evaluate myocardial and pericardial disease and direct specific treatment.</p><p></p><p class="bulletIndent1">In patients with acute CD, echocardiography often demonstrates a pericardial effusion. Left or right ventricular dilation are less commonly present. Global left ventricular ejection fraction (LVEF) is often normal or near normal, even among patients with regional wall motion abnormalities (anterior and/or apical dyskinesis or septal dyskinesis) or LV dilatation, although a minority have depressed global systolic function. Mild functional mitral regurgitation and/or tricuspid regurgitation are frequently present. Patients with acute CD with HF typically have impaired LV systolic function.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endomyocardial biopsy is generally not required to establish the diagnosis, except in patients who have undergone cardiac transplantation, when the distinction between acute Chagas myocarditis and implant rejection is crucial. The frequency of myocardial involvement in symptomatic acute CD was demonstrated by a study of 58 patients with acute CD in which myocarditis was found in all 26 undergoing endomyocardial biopsy, including eight patients with no other evidence of heart disease [<a href="#rid4">4</a>]. Typical findings are inflammatory changes with mild or no fibrosis. Intracellular <em>T. cruzi</em> amastigote nests are occasionally identified (<a class="graphic graphic_picture graphicRef53306" href="/z/d/graphic/53306.html" rel="external">picture 1</a>). Of note, this case series, in which all patients had manifestations severe enough to warrant clinical care, is not representative of the universe of acute CD, which includes many milder cases. (See  <a class="medical medical_review" href="/z/d/html/114195.html" rel="external">"Chagas disease in the immunosuppressed host", section on 'Donor-derived acute Chagas in organ transplant recipients'</a>.)</p><p></p><p class="headingAnchor" id="H27693935"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Acute Chagas heart disease has a similar presentation to other causes of myocarditis and myopericarditis; these include various infectious agents, cardiotoxins, hypersensitivity reactions, systemic disorders, and radiation (<a class="graphic graphic_table graphicRef56995" href="/z/d/graphic/56995.html" rel="external">table 1</a>). Acute CD can be distinguished from other types of myocarditis and myopericarditis by detection of parasitemia. In patients with suspected CD with criteria for endomyocardial biopsy, a biopsy may identify or rule out other causes of myocarditis. (See  <a class="medical medical_review" href="/z/d/html/4939.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4930.html" rel="external">"Myopericarditis", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/z/d/html/4923.html" rel="external">"Endomyocardial biopsy"</a>.)</p><p class="headingAnchor" id="H1108394974"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The management of acute CD with cardiac involvement includes antitrypanosomal therapy and management of complications, including HF and pericardial effusion.</p><p class="bulletIndent1"><span class="glyph">●</span>When recognized, acute CD is treated with antitrypanosomal therapy, irrespective of the transmission mechanism. The role of antitrypanosomal drugs in acute disease is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/14004.html" rel="external">"Chagas disease: Antitrypanosomal drug therapy"</a> and  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection", section on 'Management of acute and congenital T. cruzi infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HF is treated as appropriate:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute HF is treated according to standard recommendations including diuretic and vasodilator therapy as needed. (See  <a class="medical medical_review" href="/z/d/html/3454.html" rel="external">"Treatment of acute decompensated heart failure: General considerations"</a> and  <a class="medical medical_review" href="/z/d/html/3450.html" rel="external">"Treatment of acute decompensated heart failure: Specific therapies"</a> and  <a class="medical medical_review" href="/z/d/html/3495.html" rel="external">"Management of refractory heart failure with reduced ejection fraction"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with HF with reduced ejection fraction (LVEF ≤40 percent) or mid-range ejection fraction (LVEF 41 to 49 percent) should be treated according to standard recommendations. (See  <a class="medical medical_review" href="/z/d/html/117708.html" rel="external">"Treatment and prognosis of heart failure with mildly reduced ejection fraction"</a> and  <a class="medical medical_review" href="/z/d/html/121085.html" rel="external">"Overview of the management of heart failure with reduced ejection fraction in adults", section on 'Pharmacologic therapy'</a> and  <a class="medical medical_review" href="/z/d/html/121085.html" rel="external">"Overview of the management of heart failure with reduced ejection fraction in adults"</a>.)</p><p></p><p class="bulletIndent2">Management of chronic Chagas cardiomyopathy is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4925.html" rel="external">"Chronic Chagas cardiomyopathy: Management and prognosis", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with asymptomatic LV global systolic dysfunction (LVEF ≤40 percent) should be treated according to standard recommendations. (See  <a class="medical medical_review" href="/z/d/html/3509.html" rel="external">"Management and prognosis of asymptomatic left ventricular systolic dysfunction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pericardial effusion is common in acute CD and occasionally complicated by tamponade (which may occur when the effusion is large or if even a moderate amount of fluid accumulates rapidly), which is treated by urgent pericardiocentesis, as discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade"</a>.)</p><p></p><p class="headingAnchor" id="H545572657"><span class="h1">CLINICAL COURSE</span><span class="headingEndMark"> — </span>Symptoms and signs of acute Chagas myocarditis typically resolve over a period of one to three months with or without etiologic treatment [<a href="#rid9">9</a>]. Valvular regurgitation often resolves after etiologic treatment of CD.</p><p>Based upon limited data from old series, mortality for the small minority of untreated individuals with symptomatic acute CD following a triatomine bug bite has been estimated as &lt;5 percent, with the mortality rate highest among younger children and very low in adults [<a href="#rid9">9,10</a>]. For example, in the 1982 Bambuí study, mortality among patients with acute CD was 8.3 percent with mortality of 19.8 percent for patients less than two years and 0 percent for patients 11 years of age and older [<a href="#rid6">6</a>]. Mortality occurs predominantly from refractory HF, with or without encephalitis. (See  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection"</a>.)</p><p>As noted above, when the infection is acquired by the oral route, the severity of the acute disease is more pronounced and there is likely a higher risk of mortality which is caused by HF, but comparisons are difficult since limited data are available and the risk of disease varies with age [<a href="#rid3">3,5,11</a>]. In the largest reported outbreak of orally acquired acute CD, infection was confirmed in 103 of 1000 exposed children and adults in a public school community; 75 percent of infected patients were symptomatic, and there was one death in a five-year old child [<a href="#rid3">3</a>]. In a series of 13 patients aged 13 to 61 with acute orally acquired CD, two patients died [<a href="#rid5">5</a>]. In an outbreak in which 40 people were exposed, seven individuals developed cardiac and/or systemic symptoms and two patients died [<a href="#rid11">11</a>]. This is probably related to an enhanced parasite inoculation burden through active invasion mediated by attachment to the gastric mucin layer by gp82, a parasite surface molecule specific to metacyclic trypomastigotes [<a href="#rid12">12,13</a>]. (See <a class="local">'Clinical manifestations'</a> above and  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection", section on 'Acute T. cruzi infection'</a>.)</p><p>Surviving, untreated patients with acute CD proceed to chronic disease (<a class="graphic graphic_figure graphicRef114565" href="/z/d/graphic/114565.html" rel="external">figure 1</a> and <a class="graphic graphic_table graphicRef129165" href="/z/d/graphic/129165.html" rel="external">table 2</a>). The chronic phase includes two forms of disease: an indeterminate (latent, preclinical) form and a determinate (clinical) form, which is subdivided into cardiac, digestive, and cardiodigestive forms. Patients with the indeterminate form have serologic evidence of <em>T. cruzi</em> infection (presence of anti-<em>T. Cruzi</em> antibodies) without overt clinical evidence of cardiac or gastrointestinal disease. (See  <a class="medical medical_review" href="/z/d/html/114192.html" rel="external">"Chagas disease: Chronic Trypanosoma cruzi infection", section on 'Natural history'</a>.)</p><p>Limited data suggest that patients with acute CD rarely proceed directly to chronic Chagas cardiomyopathy without an intervening indeterminate phase, as described in the endemic area of Bambuí, Brazil [<a href="#rid6">6,9,10</a>]. This phenomenon is likely rare now with high rates of treatment of clinically apparent acute cases. In the hyperendemic Bolivian Chaco region, ECG abnormalities were identified in only 1.1 percent of infected individuals 10 to 19 years of age, suggesting rare direct progression from acute infection to chronic Chagas cardiomyopathy in this population [<a href="#rid14">14</a>]. Approximately one-quarter to one-half of patients with the indeterminate form of CD eventually develop chronic Chagas cardiomyopathy. (See  <a class="medical medical_review" href="/z/d/html/4955.html" rel="external">"Chronic Chagas cardiomyopathy: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H3852964170"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113058.html" rel="external">"Society guideline links: Chagas disease"</a>.)</p><p class="headingAnchor" id="H398332099"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> –<strong> </strong>Most patients with acute Chagas disease (CD) are asymptomatic or have a relatively mild nonspecific illness with generalized symptoms and signs such as fever and myalgia. A minority of patients with acute CD present with fulminant acute disease with acute myocarditis with heart failure (HF), pericardial effusion, or meningoencephalitis. HF is associated with significant risk of early mortality. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – A diagnosis of acute Chagas myocarditis is based upon identifying acute CD with associated cardiac involvement:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute infection</strong> – Acute CD should be suspected in patients with nonspecific symptoms such as malaise, fever, and anorexia who have risk factors for infection with <em>Trypanasoma cruzi</em>. A diagnosis of acute CD is generally made by detection of circulating parasites by a variety of methods. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiac disease</strong> – Cardiac disease should be suspected in patients with cardiac symptoms or signs on physical examination, ECG (<a class="graphic graphic_waveform graphicRef121871" href="/z/d/graphic/121871.html" rel="external">waveform 1</a>), or chest radiograph (<a class="graphic graphic_diagnosticimage graphicRef121856" href="/z/d/graphic/121856.html" rel="external">image 1</a>). A diagnosis of cardiac involvement is generally confirmed by echocardiography. (See <a class="local">'Diagnosis'</a> above and  <a class="medical medical_review" href="/z/d/html/114181.html" rel="external">"Chagas disease: Acute and congenital Trypanosoma cruzi infection", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of acute Chagas heart disease includes other causes of myocarditis and myopericarditis (<a class="graphic graphic_table graphicRef56995" href="/z/d/graphic/56995.html" rel="external">table 1</a>). (See <a class="local">'Differential diagnosis'</a> above and  <a class="medical medical_review" href="/z/d/html/4939.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4930.html" rel="external">"Myopericarditis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – The management of acute Chagas heart disease includes antitrypanosomal therapy and management of complications, including HF and pericardial effusion. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical course</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptoms and signs of acute Chagas myocarditis typically resolve over a period of one to three months with or without etiologic treatment (<a class="graphic graphic_figure graphicRef114565" href="/z/d/graphic/114565.html" rel="external">figure 1</a>) [<a href="#rid9">9</a>]. (See <a class="local">'Clinical course'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Untreated patients with acute CD proceed to the chronic phase which includes an indeterminate (latent) form and a determinate (clinical) form (including cardiac, digestive, and cardiodigestive presentations). Patients with acute CD rarely proceed directly to chronic Chagas cardiomyopathy without an intervening indeterminate (asymptomatic) phase. About one-quarter to one-half of patients with the indeterminate form develop chronic Chagas cardiomyopathy after a latent period ranging from 5 to 30 years. (See <a class="local">'Clinical course'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Schofield CJ, Dias JC. A cost-benefit analysis of Chagas disease control. Mem Inst Oswaldo Cruz 1991; 86:285.</a></li><li><a class="nounderline abstract_t">Nunes MCP, Beaton A, Acquatella H, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation 2018; 138:e169.</a></li><li><a class="nounderline abstract_t">Alarcón de Noya B, Díaz-Bello Z, Colmenares C, et al. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis 2010; 201:1308.</a></li><li><a class="nounderline abstract_t">Parada H, Carrasco HA, Añez N, et al. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int J Cardiol 1997; 60:49.</a></li><li><a class="nounderline abstract_t">Bastos CJ, Aras R, Mota G, et al. Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil. PLoS Negl Trop Dis 2010; 4:e711.</a></li><li><a class="nounderline abstract_t">Dias JCP. Acute Chagas Disease. Mem Inst Oswaldo Cruz 1984; 79:85.</a></li><li class="breakAll">Marin-Neto JA, Rassi Jr JA, Maciel BC, et al. Chagas Heart Disease. In: Evidence-Based Cardiology, 3rd ed, Yusuf S, Cairns J, Fallen EL, et al (Eds), BMJ Books, 2010. p.823.</li><li><a class="nounderline abstract_t">Dias JC, Kloetzel K. The prognostic value of the electrocardiographic features of chronic Chagas' disease. Rev Inst Med Trop Sao Paulo 1968; 10:158.</a></li><li><a class="nounderline abstract_t">Rassi A Jr, Rassi A, Little WC. Chagas' heart disease. Clin Cardiol 2000; 23:883.</a></li><li><a class="nounderline abstract_t">Pinto Dias JC. [Natural history of Chagas disease]. Arq Bras Cardiol 1995; 65:359.</a></li><li><a class="nounderline abstract_t">Dias JP, Bastos C, Araújo E, et al. Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop 2008; 41:296.</a></li><li><a class="nounderline abstract_t">Yoshida N. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity. Parasitol Int 2008; 57:105.</a></li><li><a class="nounderline abstract_t">Yoshida N, Tyler KM, Llewellyn MS. Invasion mechanisms among emerging food-borne protozoan parasites. Trends Parasitol 2011; 27:459.</a></li><li><a class="nounderline abstract_t">Fernandez AB, Nunes MC, Clark EH, et al. Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease. Glob Heart 2015; 10:159.</a></li></ol></div><div id="topicVersionRevision">Topic 120680 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1842419" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A cost-benefit analysis of Chagas disease control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30354432" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20307205" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9209939" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20559542" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Acute Chagas Disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Acute Chagas Disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4982469" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The prognostic value of the electrocardiographic features of chronic Chagas' disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11129673" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Chagas' heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8728813" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : [Natural history of Chagas disease].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18719812" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Acute Chagas disease outbreak associated with oral transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18234547" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21840261" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Invasion mechanisms among emerging food-borne protozoan parasites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26407511" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
